Literature DB >> 16843574

Strategies for containing a global influenza pandemic.

Antoine Flahault1, Elisabeta Vergu, Laurent Coudeville, Rebecca F Grais.   

Abstract

Mathematical modelling provides useful insight into the geographic and temporal spread of pandemic influenza. It has been recently used to assess the ability to stop a pandemic at a very early stage. Here, we model the global diffusion of pandemic influenza and the impact of available preventive and control measures. We refined a published SEIR deterministic model of disease dynamics within 52 cities interconnected via air transport to simulate the impact of five interventions in a variety of scenarios: vaccination, case isolation, therapeutic and prophylactic antiviral treatment, and air traffic reduction. The impact of these measures was assessed on the spread of a potential pandemic strain profile, with an average attack-rate of 26%, a case-fatality rate of 2.5% and a residual immunity of 25%. Our analysis highlighted the importance of: (1) a global perspective for dealing with pandemic risks; (2) the time factor and, hence, the importance of surveillance systems; (3) the complementary role of available control measures. Results provide general guidance for the issues of concern to public-health decision-makers: when to set up interventions, where, and at which administrative levels.

Mesh:

Substances:

Year:  2006        PMID: 16843574     DOI: 10.1016/j.vaccine.2006.05.079

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  42 in total

1.  Antiviral treatment for the control of pandemic influenza: some logistical constraints.

Authors:  N Arinaminpathy; A R McLean
Journal:  J R Soc Interface       Date:  2008-05-06       Impact factor: 4.118

2.  Virtual epidemic in a virtual city: simulating the spread of influenza in a US metropolitan area.

Authors:  Bruce Y Lee; Virginia L Bedford; Mark S Roberts; Kathleen M Carley
Journal:  Transl Res       Date:  2008-04-03       Impact factor: 7.012

3.  Optimal resource allocation model to mitigate the impact of pandemic influenza: a case study for Turkey.

Authors:  Melik Koyuncu; Rizvan Erol
Journal:  J Med Syst       Date:  2010-02       Impact factor: 4.460

4.  A decision-support framework to optimize border control for global outbreak mitigation.

Authors:  Aleksa Zlojutro; David Rey; Lauren Gardner
Journal:  Sci Rep       Date:  2019-02-18       Impact factor: 4.379

5.  Impact of the infection period distribution on the epidemic spread in a metapopulation model.

Authors:  Elisabeta Vergu; Henri Busson; Pauline Ezanno
Journal:  PLoS One       Date:  2010-02-26       Impact factor: 3.240

6.  Estimate of Novel Influenza A/H1N1 cases in Mexico at the early stage of the pandemic with a spatially structured epidemic model.

Authors:  Vittoria Colizza; Alessandro Vespignani; Nicola Perra; Chiara Poletto; Bruno Gonçalves; Hao Hu; Duygu Balcan; Daniela Paolotti; Wouter Van den Broeck; Michele Tizzoni; Paolo Bajardi; Jose J Ramasco
Journal:  PLoS Curr       Date:  2009-11-11

7.  Identifying cost-effective dynamic policies to control epidemics.

Authors:  Reza Yaesoubi; Ted Cohen
Journal:  Stat Med       Date:  2016-07-24       Impact factor: 2.373

8.  Scenarios of diffusion and control of an influenza pandemic in Italy.

Authors:  C Rizzo; A Lunelli; A Pugliese; A Bella; P Manfredi; G Scalia Tomba; M Iannelli; M L Ciofi degli Atti
Journal:  Epidemiol Infect       Date:  2008-02-14       Impact factor: 2.451

9.  Seasonal transmission potential and activity peaks of the new influenza A(H1N1): a Monte Carlo likelihood analysis based on human mobility.

Authors:  Duygu Balcan; Hao Hu; Bruno Goncalves; Paolo Bajardi; Chiara Poletto; Jose J Ramasco; Daniela Paolotti; Nicola Perra; Michele Tizzoni; Wouter Van den Broeck; Vittoria Colizza; Alessandro Vespignani
Journal:  BMC Med       Date:  2009-09-10       Impact factor: 8.775

10.  Potential for a global dynamic of Influenza A (H1N1).

Authors:  Antoine Flahault; Elisabeta Vergu; Pierre-Yves Boëlle
Journal:  BMC Infect Dis       Date:  2009-08-12       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.